Skip to main content

MoneyWorks4Me

Lincoln Pharmaceuticals informs about disclosure

29 Feb 2024 Evaluate

Lincoln Pharmaceuticals has informed that it enclosed the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Renukaben Maheshbhai Patel.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1771.95
Dr. Reddys Labs. 1370.00
Cipla 1392.20
Lupin 2012.00
Zydus Lifesciences 1239.00
View more..